C

Cigna Group

Sells health coverage and pharmacy benefits

PBS Engineering Managing Director

Full-TimeUpdated on 10/23/2026
$209.6k - $349.3k/yr+ Annual bonus + Long-term incentive plan
Expert
Bachelor's
Philadelphia, PA, USA+2 moreMore locations: St. Louis, MO, USA | Bloomfield, CT, USA
Hybrid
Engineering ManagementEngineering Leadership

About the job

Requirements
  • A bachelor's degree or equivalent related experience is required; an advanced degree is preferred.
  • At least 15 years of progressively responsible experience in technology, engineering, platform delivery, technology strategy, or large-scale transformation, including significant managerial experience.
  • Experience leading sizeable employee and partner populations through multiple layers of senior leaders, including directors, senior managers, principals, or equivalent roles.
  • A proven record of developing and executing medium- to long-term strategies and roadmaps with material organizational, operational, financial, and client impact.
  • Demonstrated experience introducing AI-assisted software development lifecycle practices across engineering teams, including the tooling, quality controls, and ways of working needed to realize measurable gains in a regulated delivery environment.
  • Demonstrated success influencing executives and leading outcomes across organizational boundaries without relying solely on direct authority.
  • Strong financial, portfolio, vendor, resource, capacity, risk, and performance-management capabilities.
  • Strong written, verbal, listening, and presentation skills, including the ability to absorb disparate information and clearly articulate the issue, recommendation, decision, and required action.
  • Strong executive presence, sound judgment, resilience, and ability to operate effectively in a highly complex and evolving environment.
  • Demonstrated leadership of large-scale engineering organizations across technology transformation, platform implementation, modernization, systems integration, and enterprise migration programs.
  • Deep understanding of complex application ecosystems, integration patterns, data conversion, testing, release management, production readiness, and operational support.
  • Command of modern engineering practice, including source control and branching strategy, continuous integration and continuous delivery pipelines, automated testing, environment and test data management, observability, and change and release control.
  • Experience establishing governance and delivery models across federated technology organizations and matrixed teams.
  • Ability to evaluate architecture, engineering, security, infrastructure, data, resilience, and non-functional requirements, and to make sound technical decisions at enterprise scale.
  • Experience leading client or customer implementations requiring coordinated business readiness, technical migration, cutover, contingency, and stabilization.
  • Strong command of Agile, Waterfall, and hybrid delivery approaches, with the judgment to apply fit-for-purpose methods across systems and workstreams.
  • Familiarity with AI-assisted software delivery and automation, and judgment about where they add value within an engineering organization.
  • Ability to use delivery, quality, incident, capacity, financial, and operational data to identify trends, manage risk, and guide executive decisions.
  • Ability to translate complex concepts into clear roadmaps, executive narratives, operating models, and presentation-ready recommendations.
Responsibilities
  • Develop and drive the three- to five-year engineering strategy, roadmap, governance model, and delivery approach for New PBM Platform integration, modernization, and client re-implementation.
  • Translate enterprise and executive priorities into outcomes, sequencing, investment needs, engineering and organizational capabilities, and execution plans across the PBS engineering organization.
  • Advise executive leadership on strategic direction, major delivery and technical decisions, organizational alignment, risk tradeoffs, and readiness for client migration waves.
  • Synthesize complex technical, operational, financial, and client information into narratives and presentation-ready materials that enable timely decisions and organizational commitment.
  • Represent the organization in senior leadership forums and serve as a primary interface with senior business, technology, and external partner leaders.
  • Define and own the engineering model, covering code and repository strategy, branching, environments, pipelines, automation, test approach, change control, and release governance across the existing estate.
  • Collaborate to establish how work from the Orchestration Hub and capability build arm enters the organization, including how scope is received, estimated, scheduled, built, tested, and released.
  • Raise engineering quality and throughput across teams using different models, standards, and tooling, bringing them to a consistent standard without destabilizing in-flight commitments.
  • Own the technical definition of done for engineering work, including code quality, test coverage, non-functional thresholds, and production readiness.
  • Apply AI-assisted engineering and automation where they measurably improve speed, quality, and repeatability across integration, conversion, testing, and regression work.
  • Own integrated execution of federated workstreams that modernize retained ESI capabilities and build integrations for those systems to operate with New PBM Platform.
  • Establish delivery commitments, milestones, dependency management, escalation paths, and performance measures across technology teams that retain functional reporting lines.
  • Partner with New PBM Platform’s platform organization and the Orchestration Hub to align scope, acceptance criteria, cross-arm dependencies, risks, issues, testing, and release schedules.
  • Ensure modernization and integration work meets functional, performance, security, reliability, and operational-readiness expectations before client deployment.
  • Balance New PBM Platform commitments with business-as-usual requirements so legacy services remain stable throughout the multi-year transition.
  • Lead the technical model for transitioning clients from the legacy environment to New PBM Platform through sequenced implementation waves and a single integrated plan.
  • Oversee configuration, data conversion and reconciliation, migration tooling, integration and end-to-end testing, cutover planning, contingency procedures, go/no-go readiness, command-center execution, and post-launch stabilization.
  • Partner with business readiness, account management, operations, finance, and product teams to establish wave-specific readiness criteria and ensure the technical plan supports client and operational commitments.
  • Drive repeatable migration and conversion capabilities that improve quality, speed, and predictability across successive client waves.
  • Serve as the senior technical authority on whether a migration wave is ready to proceed, ensuring each transition is executed at the required scale while protecting clients and services not yet moved to New PBM Platform.
  • Establish standards, governance, scorecards, and executive reporting for delivery health, capacity, dependencies, readiness, quality, risk, issues, and operational performance.
  • Drive resolution of complex technical incidents and delivery barriers, using data to shape recommendations, escalation decisions, and corrective action.
  • Ensure appropriate technology risk, security, compliance, resilience, and production-readiness controls are embedded across integration and migration activities.
  • Provide oversight for high-priority initiatives and cross-functional work that falls outside established ownership or requires enterprise-level coordination.
  • Maintain accountability for delivery outcomes, operational excellence, financial stewardship, and policy implementation across the organization.
  • Build and lead a scalable engineering organization spanning delivery, integrated planning, integration and end-to-end testing, migration, cutover and contingency, and business operations technical support.
  • Lead through multiple senior leaders and matrixed teams, setting clear accountability while enabling effective execution across federated organizations.
  • Recruit, develop, and retain engineering talent; establish a leadership bench and adaptable capacity model aligned to the client-wave roadmap.
  • Create a collaborative, transparent, and outcomes-focused culture that advances work through ambiguity, enterprise complexity, and competing priorities.
  • Build partnerships across Technology, Product, Operations, Account Management, Finance, Human Resources, Communications, Security, Infrastructure, Data, and external delivery partners.
  • Translate executive strategy into long-term direction for New PBM Platform integration, modernization, and client transition; anticipate future needs and connect enterprise priorities to a practical multi-year path.
  • Create accountability across complex, federated work and drive measurable outcomes under demanding timelines; integrate incomplete information and interdependencies into clear paths forward.
  • Make timely decisions using technical, business, operational, client, and risk considerations; align competing priorities across senior leaders, technology organizations, business functions, clients, and partners.
  • Build credibility through transparency, follow-through, sound judgment, and clear ownership; create an effective leadership system across direct, indirect, and matrixed teams.
  • Surface difficult issues, challenge assumptions, and escalate risk when needed to protect enterprise and client outcomes.
  • Communicate complex information concisely and in a decision-ready manner for executive, technical, business, and client audiences; establish momentum amid ambiguity and adapt leadership approach from strategy through implementation and steady-state operations.
Desired Qualifications
  • Experience in healthcare, pharmacy benefit management, regulated technology, or similarly complex transaction-processing environments.

About the company

The Cigna Group sells health coverage and pharmacy services to employers, health plans and individuals, and most of its business runs through Evernorth, its health services arm. Evernorth owns Express Scripts, one of the largest pharmacy benefit managers in the U.S., which negotiates drug prices and processes prescriptions for plan sponsors, plus the specialty pharmacy Accredo. Its Cigna Healthcare unit sells medical, dental and behavioral coverage, mostly to employers that fund their own plans, and earns premiums and administrative fees, while Evernorth earns service fees and drug margins. The company was formed in 1982 through the merger of Connecticut General and INA and is based in Bloomfield, Connecticut.

Company Size

10,001+

Company Stage

N/A

Total Funding

N/A

Headquarters

Bloomfield, CT

Founded

1982

Get referred to Cigna Group

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Profit outlook is rising: in July 2026, Cigna raised its 2026 adjusted EPS outlook to at least $30.45.
  • Specialty drugs drive growth: Specialty and Care Services pre-tax adjusted income rose 22% in Q2 2026.
  • Insiders reach the top: longtime Cigna executive Brian Evanko became CEO on July 1, 2026.

What critics are saying

  • Jobs have been cut: in February 2026, Cigna began laying off about 2,000 employees and offered voluntary separations.
  • The PBM core is shrinking: Pharmacy Benefit Services pre-tax adjusted income fell 27% in Q2 2026.
  • Consumer plans are shrinking: in April 2026, Cigna said it will exit ACA individual exchanges by 2027.

What makes Cigna Group unique

  • Pharmacy outweighs insurance: Evernorth posted $61.5 billion of Q2 2026 adjusted revenue against Cigna Healthcare's $11.7 billion.
  • It is dropping drug rebates: Express Scripts' rebate-free Signature model becomes the standard for all clients in 2028.
  • Coverage reaches abroad: Cigna Healthcare runs an international health business serving expatriates and multinational employers.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Paid Vacation
  • Paid Holidays
  • Wellness Program

Company News

PR Newswire
Jul 30th, 2026
Cigna raises 2026 outlook to $30.45 per share after Q2 revenues hit $71.7B

The Cigna Group reported strong second quarter 2026 results, with total revenues increasing 7% to $71.7 billion. Shareholders' net income reached $1.7 billion, or $6.29 per share, whilst adjusted income from operations was $2.1 billion, or $7.78 per share. Based on these results, the company raised its full-year 2026 outlook for adjusted income from operations to at least $30.45 per share, an increase of $0.10 from its previous projection. The healthcare company's performance was driven by growth across its diversified portfolio, particularly in Cigna Healthcare. Total customer relationships stood at 182.8 million at quarter end. Chief Executive Officer Brian Evanko attributed the strong performance to the company's strategy of using technology, data and artificial intelligence to deliver more personalised experiences whilst improving access and lowering costs.

VNA East
Jun 18th, 2026
Cigna Group Foundation awards $250,000 to Hartford Hospital's Food4Health program.

Cigna Group Foundation awards $250,000 to Hartford Hospital's Food4Health program. June 18, 2026 Hartford Hospital was awarded a generous $250,000 grant through The Cigna Group Health Equity Impact Fund by The Cigna Group Foundation, the philanthropic arm of The Cigna Group, to expand access to its innovative Food4Health program and reduce health disparities among underserved populations in the Hartford region. Food4Health is a prescription-based program for low-income patients experiencing food insecurity and at risk of diet-related illnesses. Participants visit the hospital's Food4Health Clinic weekly to shop for nutritious foods and recipes at no cost and receive medical guidance on healthy eating and food preparation. The clinic has had over 10,000 patient visits and distributed more than 3 million pounds of food since 2022. The Cigna Group Foundation's investment will increase access and remove barriers to Food4Health participation by providing transportation assistance, shopping carts and food delivery services to underserved patients. The program will also pilot two part-time community health workers charged with guiding Food4Health patients through transportation support, healthy lifestyle changes and access to healthcare. "Programs like Food4Health only work if people can access them," said Ellie Polack, president, The Cigna Group Foundation. "For many patients, transportation is a major barrier. As a company headquartered here in Connecticut, we're proud to support programs like this in our own community, helping more people get the food and guidance they need to improve their health." "Food4Health is changing what care can look like - bringing nutrition, clinical support and guidance together in a way that truly meets patients where they are," said Lynn B. Rossini, interim chief philanthropy officer, Hartford HealthCare, and vice president of Philanthropy at Hartford Hospital. "We're grateful to The Cigna Group Foundation for this support, which allows us to reach more patients and build the kind of lasting change that our community needs."

AlphaStreet
May 27th, 2026
Cigna (CI) has a 2026 growth story that looks bigger than medical costs.

Cigna (CI) has a 2026 growth story that looks bigger than medical costs. Why Cigna's thesis now runs through Evernorth as much as insurance. The usual shorthand on The Cigna Group is to treat it as an insurer whose stock lives and dies on medical-cost trends. That misses where most of the scale sits. In the first quarter of 2026, Cigna generated $68.5 billion of total revenue, and Evernorth Health Services alone produced $58.4 billion of adjusted revenue, compared with $11.5 billion for Cigna Healthcare adjusted revenue (The Cigna Group Q1 2026 release). Evernorth combines pharmacy benefit services with specialty and care services, giving Cigna an earnings base tied to drug mix, specialty distribution, and care delivery rather than only to insurance underwriting. That pattern was also visible in full-year 2025. Total revenue rose 11% to $274.9 billion, driven primarily by Evernorth, while adjusted income from operations increased 4% to $8.0 billion, or $29.84 per share (The Cigna Group FY2025 release). The long-run case increasingly depends on whether Evernorth can keep compounding through specialty volume and biosimilar adoption. How specialty mix and pricing discipline are shaping 2026 earnings. The first quarter shows why this is more than a simple membership story. Evernorth's adjusted revenue increased 9% year over year to $58.4 billion, while pre-tax adjusted income from operations increased 2% to $1.47 billion (The Cigna Group Q1 2026 release). The internal mix shift is the real story. Pharmacy Benefit Services revenue rose 11% to $33.0 billion, but pre-tax income fell 28% to $394 million because of expected lower contributions from large client relationships. Specialty and Care Services offset that: adjusted revenue rose 6% to $25.4 billion and pre-tax income climbed 20% to $1.07 billion, helped by specialty growth and higher generic and biosimilar adoption (The Cigna Group Q1 2026 release). Cigna Healthcare also gave the company a cleaner setup than the market often assumes. First-quarter 2026 adjusted revenue declined 21% to $11.5 billion, mainly because the Medicare businesses were sold to HCSC in March 2025, but adjusted income from operations before tax still increased 18% to $1.51 billion. The Cigna Healthcare medical care ratio improved to 79.8% from 82.2% a year earlier, and the company said underlying revenue excluding the HCSC transaction rose 8% because pricing increased to cover expected medical costs (The Cigna Group Q1 2026 release). That is a useful signal: Cigna is showing it can shrink lower-priority exposure, reprice commercial risk, and still improve profitability. Why the balance sheet and buybacks still matter to the CI story. CI is also not just a medical-cost trade because management still has capital allocation flexibility. Cigna ended March 31, 2026 with $7.0 billion of cash and cash equivalents, according to the 10-Q, and its debt-to-capitalization ratio improved to 42.3% from 43.0% at year-end 2025 (Cigna Q1 2026 10-Q). Capital return is already part of the earnings model. In full-year 2025, Cigna repurchased 11.9 million shares for about $3.6 billion, and it raised the quarterly dividend to $1.56 per share in February 2026 from $1.51 in 2025 (The Cigna Group FY2025 release). The first-quarter 2026 outlook also explicitly included the effect of expected future share repurchases, meaning buybacks are embedded in how management frames per-share earnings power (The Cigna Group Q1 2026 release). That matters after the Medicare divestiture. Cigna has already shown willingness to reshape the portfolio instead of defending every line of business. A company with a large services platform, steadier commercial pricing, and ongoing buybacks can still compound even if it no longer looks like a traditional membership-growth story. What investors should watch next in the Cigna Healthcare and Evernorth segments. The next watchpoint is whether Evernorth keeps shifting toward the parts of the business that carry better strategic value. Specialty and Care Services delivered stronger income growth than Pharmacy Benefit Services in the first quarter, so investors should watch whether biosimilar adoption and specialty volume keep offsetting pressure in large client relationships. The second watchpoint is whether Cigna Healthcare can preserve its pricing discipline without giving back the margin gains. The first-quarter medical care ratio of 79.8% was better than a year ago, but the company's full-year 2026 outlook still calls for a Cigna Healthcare medical care ratio of 83.7% to 84.7% (The Cigna Group Q1 2026 release). That implies some normalization ahead. Finally, investors should watch whether customer relationships stabilize after recent transitions. Pharmacy customers were 121.0 million at March 31, 2026, down from 123.6 million at year-end 2025, while total customer relationships fell to 185.5 million from 188.4 million (The Cigna Group Q1 2026 release). If specialty economics and commercial margins keep improving, CI can work even with modest churn. Key signals for investors. * Evernorth generated $58.4 billion of first-quarter 2026 adjusted revenue, far outweighing Cigna Healthcare's $11.5 billion, which reinforces that CI is a health-services platform as much as an insurer (The Cigna Group Q1 2026 release). * Specialty and Care Services pre-tax income rose 20% in the first quarter of 2026 even as Pharmacy Benefit Services income fell 28%, showing where the earnings mix is improving (The Cigna Group Q1 2026 release). * Cigna Healthcare's medical care ratio improved to 79.8% in Q1 2026 from 82.2% a year earlier, suggesting pricing and portfolio shaping are helping offset insurance-cost noise (The Cigna Group Q1 2026 release). * Cigna ended Q1 2026 with $7.0 billion in cash and a 42.3% debt-to-capitalization ratio, while 2025 buybacks totaled about $3.6 billion, supporting continued per-share earnings growth (Cigna Q1 2026 10-Q; The Cigna Group FY2025 release). Sources. * https://www.sec.gov/Archives/edgar/data/1739940/000114036126017971/ef20071317_ex99-1.htm * https://www.sec.gov/Archives/edgar/data/1739940/000173994026000043/ci-20260331.htm * https://www.sec.gov/Archives/edgar/data/1739940/000114036126003768/ef20064751_ex99-1.htm * https://www.sec.gov/Archives/edgar/data/1739940/000173994026000006/ci-20251231.htm * https://investors.thecignagroup.com/overview/default.aspx * https://data.sec.gov/submissions/CIK0001739940.json

The Post and Courier
May 26th, 2026
Midlands hospital system reaches agreement to be back in-network with large insurance provider.

Midlands hospital system reaches agreement to be back in-network with large insurance provider. WEST COLUMBIA - After five months without a contract, one of the Midlands' largest healthcare providers is once again in-network for customers of a large health insurance company. Lexington Health, the local healthcare network anchored by a 607-bed hospital in West Columbia, announced via its website that it has reached a multi-year contract with Cigna. "As a result, Lexington Medical Center and our affiliated physician practices will be in network with Cigna starting July 1, 2026," the hospital system said. "If you had appointments or procedures cancelled due to the disruption in our network status, you can now reschedule with your doctor's office," Lexington Health added. "If you have any coverage or plan-specific questions, please contact Cigna at the phone number on the back of your insurance card. We appreciate your support of Lexington Medical Center and our network of care. Thank you for choosing us to care for you and your family." In a release, Lexington Health said that patients will receive notifications via MyChart and mailed letters, and patients who previously had procedures or appointments canceled due to being out-of-network with Cigna can contact their providers' office to reschedule. Lexington Health and Cigna reconnect. The hospital first announced that it would shift to being out-of-network for Cigna customers in early December. The change went into effect at the start of 2026. At the time, Lexington Health said it was not able to reach a "fair and sustainable agreement" despite "working in good faith." Cigna previously said Lexington Health was demanding double-digit rate hikes that would "make care unaffordable." "Reaching a fair and sustainable agreement requires time and continued dialogue," Lexington Health CFO Jeff Brillhart said in a release. "We are pleased to have this negotiation finalized, and most importantly, we sincerely thank our patients for their trust and understanding throughout this process." In absence of an agreement, Cigna customers faced significantly higher costs if they continued to utilize Lexington Health's services. Emergency care was still treated as in-network. Cigna is one of the largest health insurance providers in the country, with over 67,700 employees and 185 million customers worldwide, according to the company's website. "We are pleased to have reached agreement with Lexington Medical Center to bring them back into the Cigna network, restoring in-network access for the community we both serve," Cigna said in a provided statement. "Together, we will continue efforts to improve health and vitality for our customers and their families."

DistilInfo
May 14th, 2026
Eric Palmer joins AMN Healthcare board of directors.

Eric Palmer joins AMN Healthcare board of directors. Healthcare staffing leader AMN Healthcare has appointed former Cigna Group executive Eric Palmer to its board of directors. The company announced the move on May 13, 2026. Palmer brings deep industry knowledge and decades of executive-level experience. His addition signals AMN Healthcare's focus on strengthening its strategic leadership. Who is Eric Palmer? Eric Palmer is a veteran healthcare executive with a career spanning more than 25 years. He built his professional foundation entirely at Cigna Group. During his long tenure, he rose through the ranks to hold some of the company's most senior positions. He departed Cigna in April 2025 after a distinguished run at the top of the organization. His key roles at Cigna. Palmer's career at Cigna was marked by significant leadership milestones. Most recently, he served as CEO of Evernorth Health Services, Cigna's health services segment. Before that, he held the role of Chief Financial Officer (CFO) for the broader Cigna organization. His time as CFO was particularly impactful. He played a central role in Cigna's landmark acquisition of pharmacy benefit manager Express Scripts. That deal reshaped Cigna's business model and expanded its footprint in the pharmacy and specialty health services space. Consequently, Palmer earned a reputation as a dealmaker and strategic thinker at the highest levels of corporate healthcare. Why AMN Healthcare chose Palmer. AMN Healthcare selected Palmer for his proven record across several critical areas. According to the company's May 13 news release, he brings a "strong track record of leading large-scale operations." Additionally, he has deep experience in driving strategic growth initiatives. Furthermore, he has successfully executed complex mergers, acquisitions, and divestitures throughout his career. A strong fit for the board. Palmer's background aligns closely with AMN Healthcare's current priorities. The company operates in a competitive and rapidly evolving healthcare staffing market. Therefore, board-level expertise in operations, finance, and M&A is especially valuable. His familiarity with the healthcare ecosystem also gives him a distinctive edge compared to generalist board candidates. What this means for AMN Healthcare. AMN Healthcare is navigating a dynamic period in the healthcare staffing industry. Workforce shortages continue to challenge hospitals and health systems across the country. Against this backdrop, strong governance and strategic leadership are more important than ever. Palmer's appointment directly addresses this need. His experience scaling complex organizations will support AMN Healthcare's long-term growth strategy. Moreover, his understanding of payer-provider dynamics adds a dimension of insight that the board previously lacked. As a result, AMN Healthcare is better positioned to respond to market shifts, regulatory changes, and staffing demand fluctuations. Leadership Perspective from the CEO. AMN Healthcare President and CEO Cary Grace welcomed the appointment enthusiastically. She highlighted several reasons the board selected Palmer. "Eric's extensive leadership experience, understanding of the healthcare ecosystem and alignment to our mission make him a valuable addition to our board," Grace said. She added that his ability to scale complex organizations and navigate dynamic market environments would strengthen governance and support AMN's long-term goals. Grace's remarks underscore that this is not simply a symbolic appointment. Rather, Palmer joins AMN Healthcare's board with a clear mandate to contribute meaningfully to its strategic direction. About AMN Healthcare. AMN Healthcare is one of the largest healthcare staffing and workforce solutions companies in the United States. The company serves hospitals, health systems, and other healthcare facilities nationwide. Its services include travel nurse staffing, physician staffing, allied health staffing, and workforce technology solutions. A growing governance focus. AMN Healthcare has consistently invested in building a diverse and experienced board. Each new member brings specific expertise relevant to the company's evolving needs. Palmer's addition continues this pattern. His finance, operations, and health services background complements the existing board's capabilities. Conclusion. Eric Palmer's appointment to AMN Healthcare's board of directors marks a notable move in healthcare executive leadership circles. His 25-plus-year career at Cigna, including roles as Evernorth CEO and Cigna CFO, gives him rare breadth and depth. AMN Healthcare gains a board member with proven skills in M&A, large-scale operations, and strategic growth. As the healthcare staffing industry faces ongoing workforce challenges, this appointment positions AMN Healthcare to navigate complexity with experienced guidance at the top.